Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,113 | 8 | 45.6% |
| Honoraria | $6,600 | 5 | 24.8% |
| Food and Beverage | $3,793 | 125 | 14.3% |
| Travel and Lodging | $3,000 | 10 | 11.3% |
| Gift | $1,013 | 2 | 3.8% |
| Education | $48.15 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS, LLC | $23,158 | 35 | $0 (2020) |
| USWM, LLC | $1,078 | 6 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $496.30 | 22 | $0 (2024) |
| Alkermes, Inc. | $434.51 | 20 | $0 (2024) |
| ABBVIE INC. | $355.97 | 18 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $355.79 | 22 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $198.15 | 7 | $0 (2023) |
| Indivior Inc. | $135.49 | 6 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $90.29 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $76.21 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $476.67 | 24 | Teva Pharmaceuticals USA, Inc. ($90.41) |
| 2023 | $927.43 | 48 | ABBVIE INC. ($199.61) |
| 2022 | $1,498 | 26 | USWM, LLC ($1,078) |
| 2021 | $86.61 | 5 | Alkermes, Inc. ($40.25) |
| 2020 | $7,853 | 19 | PORTOLA PHARMACEUTICALS, LLC ($7,753) |
| 2019 | $290.24 | 9 | Alkermes, Inc. ($155.63) |
| 2018 | $15,435 | 22 | PORTOLA PHARMACEUTICALS, INC. ($15,405) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $26.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $26.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: CNS | ||||||
| 09/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Neuroscience | ||||||
| 07/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Neurology | ||||||
| 05/22/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: CNS | ||||||
| 05/02/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Neuroscience | ||||||
| 04/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: PSYCHIATRY | ||||||
| 04/23/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Central Nervous System | ||||||
| 04/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Central Nervous System | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CNS | ||||||
| 03/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CNS | ||||||
| 02/25/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Neurology | ||||||
| 02/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Neurology | ||||||
| 02/01/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Neuroscience | ||||||
| 01/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: NEUROSCIENCE | ||||||
| 01/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 14 | $2,102 | $1,249 |
| 2021 | 2 | 41 | 106 | $14,589 | $7,222 |
| 2020 | 2 | 49 | 86 | $10,264 | $5,300 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 14 | $2,102 | $1,249 | 59.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 88 | $14,207 | $7,086 | 49.9% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 12 | 18 | $382.50 | $136.00 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 68 | $9,321 | $4,725 | 50.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 18 | $943.00 | $574.84 | 61.0% |
About Dr. James Groce, MD
Dr. James Groce, MD is a Forensic Psychiatry healthcare provider based in Smithfield, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1811090566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Groce, MD has received a total of $26,567 in payments from pharmaceutical and medical device companies, with $476.67 received in 2024. These payments were reported across 153 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($12,113).
As a Medicare-enrolled provider, Groce has provided services to 101 Medicare beneficiaries, totaling 206 services with total Medicare billing of $13,771. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Forensic Psychiatry
- Other Specialties Psychiatry
- Location Smithfield, NC
- Active Since 09/07/2006
- Last Updated 01/02/2008
- Taxonomy Code 2084F0202X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811090566
Products in Payments
- BEVYXXA (Drug) $15,405
- ANDEXXA (Biological) $7,753
- ZIMHI (Drug) $1,043
- INVEGA SUSTENNA (Drug) $430.19
- VRAYLAR (Drug) $385.96
- ARISTADA (Drug) $240.01
- INGREZZA (Drug) $198.15
- AUSTEDO (Drug) $153.50
- SUBLOCADE (Drug) $135.49
- ABILIFY MAINTENA (Drug) $110.81
- UZEDY (Drug) $104.35
- Austedo XR (Drug) $97.94
- Vivitrol (Drug) $92.21
- CAPLYTA (Drug) $90.29
- LATUDA (Drug) $63.41
- VIVITROL (Drug) $60.40
- LYBALVI (Drug) $41.89
- INVEGA TRINZA (Drug) $36.54
- Lucemyra (Drug) $35.86
- SPRAVATO (Drug) $29.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.